Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis

British Journal of Dermatology

Volumn 149, Issue 2, 2003, Pages 363-369

  Hoefnagel, J J ^a   Thio, H B ^b   Willemze, R ^a   Bouwes Bavinck, J N ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fumaric acid esters; Long term safety; Psoriasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIPSORIASIS AGENT; CREATININE; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; ENZYME ASSAY; EOSINOPHILIA; FATIGUE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LIVER LEVEL; LIVER TOXICITY; LONG TERM CARE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SIDE EFFECT; SYSTEMIC THERAPY; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUMARATES; HUMANS; LIVER; LYMPHOPENIA; MALE; MIDDLE AGED; PSORIASIS;

EID: 0042413498     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05433.x     Document Type: Article

References (18)

1. Schweckendieck W. Heilung von Psoriasis. Med Monatschr 1959; 13: 103-4.
2. Schäfer GN. Fumarsäure lindert die Schuppenflechte. Selecta 1984; 15: 1260-1.
3. Nieboer C, de Hoop D, Langendijk PN et al. Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester. Dermatologica 1990; 181: 33-7.
4. Nugteren-Huying WM, van der Schroeff IG, Hermans J, Suurmond D. Fumaric acid therapy for psoriasis: a randomized placebo-controlled study. J Am Acad Dermatol 1990; 22: 311-12.
5. Altmeyer PJ, Matthes U, Pawlak F et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994; 30: 977-81.
6. Mrowietz U, Christophers E. Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. Br J Dermatol 1998; 138: 456-60.
7. Kolbach DN, Nieboer C, Fumaric acid therapy in psoriasis, results and side-effects of 2 years of treatment. J Am Acad Dermatol 1992; 27: 769-71.
8. Thio HB, van der Schroeff JG, Nugteren-Huying WM, Vermeer BJ. Long-term systemic therapy with dimethylfumarate and monoethylfumarate (Fumaderm) in psoriasis. J Eur Acad Dermatol Venereol 1995; 4: 35-40.
9. Peeters AJ, Dijkmans BAC, van der Schroeff JG. Fumaric acid therapy for psoriatic arthritis. Br J Rheumatol 1992; 31: 5024.
10. Ockenfels HM, Schultewolter T, Ockenfels G et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokines and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139: 390-5.
11. de Jong P, Bezemer AC, Zomerdijk TP et al. Selective stimulation of T helper 2 cytokine responses by the antipsoriasis agent monomethyl-fumarate. Eur J Immunol 1996; 26: 2067-74.
12. Stool TJ, Flier J, Sampat S et al. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 2001; 144: 1114-20.
13. Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters. J Invest Dermatol 2001; 116: 203-8.
14. Thio HB. Zomerdijk TPL. Oudshoorn C et al. Fumaric acid derivatives evoke a transient increase of intracellular free calcium concentration and inhibit the proliferation of human keratinocytes. Br J Dermatol 1994; 131: 856-61.
15. Dubiel W, Happle R. Behandlungsversuch mit Fumarsäuremonoä thylester bei Psoriasis vulgaris. Z Haut Geschlechtskr 1972; 47: 545-50.
16. Roodnat JI, Christiaans MHL, Nugteren-Huying WM et al. Akute Niereninsuffizienz bei der Behandlung der Psoriasis mit Fumarsäure-Estern. Schweiz Med Wochenschr 1989; 119: 826-30.
17. Dalhoff K, Faerber P, Arnoldt H et al. Akutes Nierenversagen unter Psoriasistherapie mit Fumarsäurederivaten. Dtsch Med Wochenschr 1990; 115: 1014-17.
18. Mrowietz U, Christophers E, Altmeyer PJ. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999; 141: 424-9.